explore -WSS

explore

author：knowledge 2025-09-30 17:29:02 - browse：117

Three boxes of Wegovy stands in a line — coverage from STAT — Steffen Trumpf/picture alliance/Getty Images

WASHINGTON — Novo Nordisk’s newly won permission to market the heart benefits of its obesity drug Wegovy could provide a backdoor way to expand access to the drug for people on Medicare, experts told STAT.

Currently, Medicare is prohibited by law from covering medications for obesity treatment alone. While companies that manufacture wildly popular anti-obesity medications and their allies haven’t been successful in lobbying Congress to change the law, the Food and Drug Administration’s move could give doctors an avenue to prescribe the medications to some Medicare patients.

Wegovy’s new label indicates that the drug can be used to reduce the risk of major heart complications for people who are overweight or obese and have existing heart disease, Novo said in a statement Friday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Republicans love RFK Jr. What's that tell us about health in 2024?

hotspot

WSS

Trans patients at the end of life deserve respect and dignity

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Florida Supreme Court upholds state's abortion ban

FDA greenlights medical device to combat bladder issues

Scientists uncover potential path to treating deadly childhood tumor

Researchers test human milk's ability to repair gut microbiome

focus

explore

Wikipedia

What does generative AI mean for health care? We asked experts

Pancreatic cancer is often deadly, but new discoveries are raising hope

ChatGPT in medicine: STAT answers readers' burning questions

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Bright Health sells Medicare Advantage business to Molina

Study: Spinal cord stimulation helps patients with paralysis walk again

Hollywood unions extend contract negotiations for actors

U.K. decision on ALS drug has neurologists, advocates up in arms

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: Biogen, Eisai, Aardvark Therapeutics, etc.

entertainment

Insurer loopholes limit power of law against surprise medical bills

People with mental disorders often marry others with same

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Republicans love RFK Jr. What's that tell us about health in 2024?

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

Kellogg’s is going to war over Mexico’s nutrition label rules

leisure time

hotspot

knowledge

leisure time